Abstract:Background: The carefully orchestrated events that result in a protective immune response are coordinated to a large extent by cytokines produced by T helper 1 (Th1) and T helper 2 (Th2) T-cell subsets, which are two arms of the immune system, Th1 cells preferentially produce interleukin 2 (IL-2), interferon gamma (IFN gamma), and tumor necrosis factor (TNF), resulting in a cellular response that helps to eliminate infected cells, In contrast, Th2 cells produce IL-4, IL-5, IL-6, and IL-10 and stimulate an antibody response that helps to prevent the cells from becoming infected, The clinical progression of several infectious diseases, including human immunodeficiency virus, some types of parasitoses, and tuberculosis, is thought to be associated with the predominance of a Th2-type T-cell response, Recent reports have demonstrated the presence of T cells producing Th2 lymphokines (IL-4, IL-6, and IL-10) in tumor-infiltrating lymphocytes of renal cell carcinoma, Purpose: The purpose of this study was to investigate at the molecular level whether there was any change in the splenic T cells of mice with progressively growing tumors from a Th1 to a Th2 DNA-binding pattern or phenotype, Methods: Splenic T cells from mice bearing renal cell carcinoma or MCA-38 colon carcinoma were tested for cytokine production after in vitro activation, Nuclear extracts of splenic T cells were used for the DNA-binding assay using IFN-gamma core promoter region, the kappa B (kappa B) Site from immunoglobulin gene, and the nuclear factor of activated T-cell (NFAT) site from IL-2 gene, Results: Splenic T cells from mice bearing renal cell carcinoma or MCA-38 colon carcinoma preferentially produced Th2 cytokines (i.e., IL-4) upon activation and showed a marked decrease in Th1 cytokine (particularly IFN gamma) production compared with the production observed in normal splenic T cells, The DNA-binding assay with the IFN-gamma core promoter region confirmed the gradual decline in the nuclear transcription factors associated with the Th1 phenotype during tumor progression in both tumor models, Renal cell carcinoma-bearing mice, successfully treated with flavone-8-acetic acid and recombinant human IL-2, showed a reversion to a Th1-like pattern, In addition, nuclear extracts of T cells from tumor-bearing animals showed a Th2-type kappa B-binding pattern, Moreover, the NFAT complex present in the normal splenic T cells was lost at the later stages of tumor progression; instead, a new complex was present in mice bearing long-term tumors, Conclusion: T cells from tumor-bearing mice lose the Th1 phenotype with progressive tumor growth.

Alterations In Nf-Kappa-B/Rel Family Proteins In Splenic T-Cells From Tumor-Bearing Mice And Reversal Following Therapy

Activity of Recombinant Human Interleukin-15 Against Tumor Recurrence and Metastasis in Mice

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth.

Changes in the Activity of Genes Involved in the Regulation of Hematopoiesis during Tumorigenesis in Irradiated Mice

Adoptive Transfer of Tumor-Reactive Transforming Growth Factor-β–Insensitive Cytolytic T Cells for Treatment of Established Mouse Renca Tumors

Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.

Diminished Expression of Transcription Factors Nuclear Factor Kappab and CCAAT/enhancer Binding Protein Underlies a Novel Tumor Evasion Mechanism Affecting Macrophages of Mammary Tumor-Bearing Mice.

In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms

Anti-Tumor Immune Responses in Immune-Reconstituted Mice Injected with A Tumor Vaccine

Tumor Necrosis Factor-Α Alters Protein Metabolism and Cell-Cycle Kinetics in Malignant Tumor

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

The NF-κB1/p50 Subunit Influences the Notch/IL-6-Driven Expansion of Myeloid-Derived Suppressor Cells in Murine T-Cell Acute Lymphoblastic Leukemia

Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease

Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia

Use Of Bioluminescent Imaging To Investigate The Role Of Nuclear Factor-Kappa B In Experimental Non-Small Cell Lung Cancer Metastasis

NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells

Treatment-Enhanced CD4+Foxp3+ Glucocorticoid-Induced TNF Receptor Family RelatedHigh Regulatory Tumor-Infiltrating T Cells Limit the Effectiveness of Cytokine-Based Immunotherapy

Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment

The Alterations of Chemokines Related to Dendritic Cells in Rats with Hepatic Carcinoma Treated by Radiofrequency Ablation

NK cells promote cancer immunoediting through tumor-intrinsic loss of interferon-stimulated gene expression

[Impact of Radiofrequency on Splenocyte Immunity of Mice Bearing H22 Liver Cancer].